\-\ Texto\\:\\ \ \(0\)\
\-\ normal\ \(4026\)\
\-\ biopsy\ \(441\)\
\-\ \\â\\€\\¢\\ mass\\ lesion\\ right\\ parietal\\ lobe\\.\ \(0\)\
\-\ \\â\\€\\¢\\ high\\ signal\\ intensity\\ of\\ t2\\ and\\ low\\ si\\ on\\ t1\\ scans\\.\ \(0\)\
\-\ \\â\\€\\¢\\ no\\ enhancement\\ following\\ contrast\\ administration\\.\ \(0\)\
\-\ \\â\\€\\¢\\ no\\ restricted\\ diffusion\\.\ \(0\)\
\-\ astrocytoma\\,\\ who\\ grade\\ 2\ \(0\)\
\-\ \\â\\€\\¢\\ primary\\ brain\\ tumor\\ infiltrating\\ white\\ matter\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ tumor\\ with\\ vasogenic\\ edema\ \(0\)\
\-\ \\â\\€\\¢\\ cerebral\\ infarction\\ with\\ re\\-perfusion\ \(0\)\
\-\ previously\\ healthy\\ 41\\ year\\ old\\ woman\\ had\\ visual\\ problems\\ at\\ work\\ followed\\ by\\ headache\\.\ \(0\)\
\-\ previous\\ ct\\ scan\\ obtained\\ during\\ her\\ er\\ visit\\ revealed\\ a\\ brain\\ mass\\ that\\ was\\ further\\ characterized\\ with\\ mr\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ brain\\:\\ 0\\.2119428488598621\ \(0\)\
\-\ si\\:\\ 0\\.20039395883252753\ \(0\)\
\-\ tumor\\:\\ 0\\.177829445639994\ \(0\)\
\-\ visit\\:\\ 0\\.17533860101286564\ \(0\)\
\-\ vasogenic\\:\\ 0\\.16720715861976157\ \(0\)\
\-\ infiltrating\\:\\ 0\\.1667656687272597\ \(0\)\
\-\ characterized\\:\\ 0\\.1561806031237341\ \(0\)\
\-\ 41\\:\\ 0\\.1558749591860662\ \(0\)\
\-\ scans\\:\\ 0\\.1479164821268844\ \(0\)\
\-\ problems\\:\\ 0\\.14745445701637455\ \(0\)\
\-\ restricted\\:\\ 0\\.14610986702138498\ \(0\)\
\-\ visual\\:\\ 0\\.14503393706394827\ \(0\)\
\-\ healthy\\:\\ 0\\.1442003156384515\ \(0\)\
\-\ diffusion\\:\\ 0\\.14319004862940354\ \(0\)\
\-\ work\\:\\ 0\\.13859635487338853\ \(0\)\
\-\ parietal\\:\\ 0\\.13726428852753753\ \(0\)\
\-\ previously\\:\\ 0\\.13646100477834233\ \(0\)\
\-\ administration\\:\\ 0\\.1353715875961057\ \(0\)\
\-\ infarction\\:\\ 0\\.1334483382020432\ \(0\)\
\-\ mass\\:\\ 0\\.12986341573017854\ \(0\)\
\-\ matter\\:\\ 0\\.12943330384510116\ \(0\)\
\-\ previous\\:\\ 0\\.1284480893996864\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.1283271966469219\ \(0\)\
\-\ er\\:\\ 0\\.12714450084817597\ \(0\)\
\-\ grade\\:\\ 0\\.1222377268383647\ \(0\)\
\-\ intensity\\:\\ 0\\.12070426841213912\ \(0\)\
\-\ obtained\\:\\ 0\\.12024080615168388\ \(0\)\
\-\ biopsy\\:\\ 0\\.11915704953033175\ \(0\)\
\-\ cerebral\\:\\ 0\\.11777075200902856\ \(0\)\
\-\ headache\\:\\ 0\\.11718395341817348\ \(0\)\
\-\ followed\\:\\ 0\\.11479229433453293\ \(0\)\
\-\ white\\:\\ 0\\.11215469953242346\ \(0\)\
\-\ revealed\\:\\ 0\\.11146164451230797\ \(0\)\
\-\ further\\:\\ 0\\.11071745090200091\ \(0\)\
\-\ no\\:\\ 0\\.11055773947407657\ \(0\)\
\-\ mr\\:\\ 0\\.10999139007080398\ \(0\)\
\-\ during\\:\\ 0\\.10767139494104716\ \(0\)\
\-\ her\\:\\ 0\\.10620021651490087\ \(0\)\
\-\ t1\\:\\ 0\\.1059144998229622\ \(0\)\
\-\ primary\\:\\ 0\\.10452561740139399\ \(0\)\
\-\ following\\:\\ 0\\.1019779445511149\ \(0\)\
\-\ edema\\:\\ 0\\.10138587164451349\ \(0\)\
\-\ scan\\:\\ 0\\.10085328192102438\ \(0\)\
\-\ with\\:\\ 0\\.09985860274112253\ \(0\)\
\-\ lobe\\:\\ 0\\.09823635698976263\ \(0\)\
\-\ enhancement\\:\\ 0\\.09784338396299144\ \(0\)\
\-\ t2\\:\\ 0\\.09780003846780504\ \(0\)\
\-\ low\\:\\ 0\\.09754128121812494\ \(0\)\
\-\ high\\:\\ 0\\.09661127595779076\ \(0\)\
\-\ signal\\:\\ 0\\.09636259560489233\ \(0\)\
\-\ who\\:\\ 0\\.0961569355568314\ \(0\)\
\-\ metastatic\\:\\ 0\\.0932311058454844\ \(0\)\
\-\ woman\\:\\ 0\\.08853143750165951\ \(0\)\
\-\ had\\:\\ 0\\.08469535387996874\ \(0\)\
\-\ contrast\\:\\ 0\\.08259475392370402\ \(0\)\
\-\ lesion\\:\\ 0\\.08149707010544156\ \(0\)\
\-\ that\\:\\ 0\\.07376935985120907\ \(0\)\
\-\ by\\:\\ 0\\.07218768611566356\ \(0\)\
\-\ normal\\:\\ 0\\.06940584749025143\ \(0\)\
\-\ ct\\:\\ 0\\.06471685457183307\ \(0\)\
\-\ at\\:\\ 0\\.0642074400699105\ \(0\)\
\-\ was\\:\\ 0\\.059243258003359466\ \(0\)\
\-\ right\\:\\ 0\\.05635877557948334\ \(0\)\
\-\ year\\:\\ 0\\.05238762426040477\ \(0\)\
\-\ on\\:\\ 0\\.05133994984767463\ \(0\)\
\-\ old\\:\\ 0\\.05031025371616067\ \(0\)\
\-\ and\\:\\ 0\\.03512638790903802\ \(0\)\
\-\ of\\:\\ 0\\.03326632429286945\ \(0\)\
